Taken together, we disclose that miR-107/CAB39/AMPK/mTOR signal pathway is partially involved in the effect of DCA on increasing chemosensitivity, thus providing a promising target for CRC treatment. The gene discussed is CAB39; the disease is colorectal carcinoma.